| Literature DB >> 34539159 |
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been detected in untreated and treated wastewater and studies have shown that the concentration of SARS-CoV-2 is proportional to the prevalence of the coronavirus disease 2019 (COVID-19) in communities. This article presents a literature review of the prevalence of SARS-CoV-2 in wastewater, its environmental fate, recommended treatment strategies for contaminated wastewater, and treatment challenges to be faced in the future. The environmental fate of SARS-CoV-2 in wastewater is not straightforward because it can be a source of infection when present in the treated wastewater depending on the permeability of the wastewater treatment plant containment area, and can also leach into aquifers, which may serve as drinking water supplies. Secondly, there are different practices that can mitigate the SARS-CoV-2 infection rate from infected feces and urine. The World Health Organization has recommended the use of ultraviolet radiation (UV), disinfection, and filtration for wastewater contaminated with SARS-CoV-2, processes also common in wastewater treatment facilities. This article discusses these strategies referencing studies performed with surrogate viruses and shows that SARS-CoV-2 treatment can be complicated due to the interference from other aqueous chemical and physical factors. Considering that COVID-19 is not the first and certainly not the last pandemic, it is imperative to develop an effective multitreatment strategy for wastewater contaminated with contagious viruses and, preferably, those that are compatible with current wastewater treatment methods.Entities:
Year: 2021 PMID: 34539159 PMCID: PMC8441782 DOI: 10.1002/rem.21691
Source DB: PubMed Journal: Remediation (N Y) ISSN: 1051-5658
Figure 1Fate of SARS‐CoV‐2 in wastewater and the infection cycle
Figure 2General steps in the wastewater treatment process
An overview of some of the wastewater treatment strategies discussed in this article and factors influencing the treatments
| Wastewater treatment | Virus tested | Factor(s) influencing the treatment for the elimination/concentration decrease of the virus | References |
|---|---|---|---|
| UV | SARS‐CoV | UV wavelength intensity | Darnell et al. ( |
| SARS‐CoV‐2 strain PA | Exposure duration | Duan et al. ( | |
| Adenovirus | Use of hydrogen peroxide | Bounty et al. (2021) | |
| Bacteriophage MS2 | Algal extracellular organic extract | Wang et al. ( | |
| UV‐C | MERS CoV | UV wavelength intensity and exposure duration | Bedell et al. ( |
| Bacteriophages MS2 and phi6 | Exposure duration | Cadnum et al. ( | |
| SARS‐CoV‐2 | Air flow | Qiao et al. ( | |
| Chlorination | SARS‐CoV‐2 | Acidic electrolyzed water | Takeda et al. ( |
| Bacteriophages MS2, phi6, X174 | Concentration of chlorine | Strasser ( | |
| Chlorine dioxide | Murin coronavirus A59 | Dose | |
| Sodium hypochlorite | Human coronavirus 229E | Color additive | Tyan et al. ( |
| Multi‐walled carbon nanotubes | Bacteriophage MS2 | Dissolved organic carbon | Jacquin et al. ( |
| Titanium anode | Bacteriophage MS2 | Salt concentration | Fang et al. ( |
| High rate algal pond | F‐RNA bacteriophage | Conditions for algal growth and oxygen production | Young et al. ( |
| Alga – | Bacteriophage MS2 | Sodium hypochlorite, calcium ions, natural organic matter | Tang et al. ( |
| Algal organic matter | Bacteriophage MS2 | Intracellular and extraceullar algal organic matter concentrations | Wu et al. ( |
| Membrane bioreactor | SARs‐CoV‐2 | Membrane size range | Lesimple et al. ( |
| Photocatalytic membrane reactor | Bacteriophage MS2 | Chlorine and pH | Horovitz et al. ( |
| Electrochemical membrane bioreactor | Bacteriophage MS2 | Electrochemical membrane | Chen et al. ( |